Literature DB >> 8880103

Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.

H Schütte1, J Lohmeyer, S Rosseau, S Ziegler, C Siebert, H Kielisch, H Pralle, F Grimminger, H Morr, W Seeger.   

Abstract

The aim of this study was to investigate whether bronchoalveolar lavage (BAL) and serum levels of proinflammatory cytokines discriminate between different entities of patients with acute respiratory failure. BAL and circulating concentrations of interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha) were measured in 74 mechanically-ventilated patients and 17 healthy controls. Patients were classified as cardiogenic pulmonary oedema (CPO), acute respiratory distress syndrome (ARDS), primary severe pneumonia (PN) and a combined group (PN+ARDS). In all patients with ARDS and/or PN, markedly elevated BAL levels of IL-6 and IL-8 were detected, which were significantly greater than levels in CPO and healthy controls. Absolute quantities and time-course of these cytokines did not differentiate between the absence and presence of lung infection, or different categories of PN. Similarly, circulating IL-6 levels were comparably elevated in patients with ARDS and/or PN, whereas circulating IL-8 concentrations were inconsistently increased. TNF-alpha was rarely detected in BAL samples, but increased serum concentrations were measured in ARDS and/or PN patients. Bronchoalveolar lavage levels of interleukin-6 and interleukin-8, but not tumour necrosis factor-alpha, and serum concentrations of interleukin-6 are consistently elevated in acute respiratory distress syndrome and/or severe pneumonia, discriminating these entities from cardiogenic pulmonary oedema. Alveolar and systemic cytokine profiles do not differentiate between acute respiratory distress syndrome in the absence of lung infection and states of severe primary or secondary pneumonia, which evidently present with comparable local and systemic inflammatory sequelae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880103     DOI: 10.1183/09031936.96.09091858

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  55 in total

Review 1.  Histopathology of ventilator-associated pneumonia (VAP) and its clinical implications.

Authors:  A Torres; N Fábregas; Y Arce; M A López-Boado
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.

Authors:  Rachel Z Blumhagen; Brenna R Hedin; Kenneth C Malcolm; Ellen L Burnham; Marc Moss; Edward Abraham; Tristan J Huie; Jerry A Nick; Tasha E Fingerlin; Scott Alper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

Review 3.  Biomarkers in acute lung injury.

Authors:  Maneesh Bhargava; Chris H Wendt
Journal:  Transl Res       Date:  2012-02-07       Impact factor: 7.012

4.  Immunohistochemical expression of MPO, CD163 and VEGF in inflammatory cells in acute respiratory distress syndrome: a case report.

Authors:  Milan Maretta; Stefan Toth; Zuzana Jonecova; Peter Kruzliak; Peter Kubatka; Stanislava Pingorova; Jarmila Vesela
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Corticosteroids in the treatment of severe community-acquired pneumonia.

Authors:  Tasha D Ramsey; Sean K Gorman
Journal:  Curr Infect Dis Rep       Date:  2014-05       Impact factor: 3.725

6.  Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells.

Authors:  G C Beck; B A Yard; A J Breedijk; K Van Ackern; F J Van Der Woude
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

7.  Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases.

Authors:  J Lohmeyer; J Friedrich; F Grimminger; U Maus; R Tenter; H Morr; H G Velcovsky; W Seeger; S Rosseau
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

8.  Analysis of serum cytokines in patients with severe acute respiratory syndrome.

Authors:  Yuanchun Zhang; Jing Li; Yuliang Zhan; Lianqiu Wu; Xueying Yu; Wenjian Zhang; Liya Ye; Shiqing Xu; Ruihua Sun; Yunting Wang; Jinning Lou
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.

Authors:  Silvia Fernández-Serrano; Jordi Dorca; Mercè Coromines; Jordi Carratalà; Francesc Gudiol; Frederic Manresa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Pulmonary edema and pleural effusion in norepinephrine-stimulated rats--hemodynamic or inflammatory effect?

Authors:  Beate Rassler; Christian Reissig; Wilfried Briest; Andrea Tannapfel; Heinz-Gerd Zimmer
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.